MedDataX Logo

Acute Anterior Uveitis: Psychic Burden and Pain

NCT ID: NCT01156285

Last Updated: 2011-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-05-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute anterior uveitis (AU) is a common reason for attendance at ophthalmic outpatient clinics. The painfulness and the fear of a transient or even persistent loss of vision may markedly reduce the individual's subjective well-being and pose a psychological burden.

This study will test the hypothesis that during an attack of AU the patient experiences a marked reduction in psychological and physical well-being.

Prospective, hospital-based epidemiologic study using a patient questionnaire with standardized psychological tests and a pain scale.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Uveitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AAU

patient with acute attack of anterior uveitis

Filling in a patient questionnaire

Intervention Type OTHER

Filling in a patient questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Filling in a patient questionnaire

Filling in a patient questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute attack of anterior uveitis

Exclusion Criteria

* Other forms of uveitis
* Chronic anterior uveitis
* Therapy started
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Graz

OTHER

Sponsor Role collaborator

Hospital Hietzing

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Saskia M Maca

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saskia M Maca, MD

Role: STUDY_DIRECTOR

Hospital Hietzing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Ophthalmology, Medical University Graz

Graz, Styria, Austria

Site Status NOT_YET_RECRUITING

Department of Ophthalmology, Hietzing Hospital

Vienna, Vienna, Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Saskia M Maca, MD

Role: CONTACT

Phone: +43-1-80110

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andreas Wedrich, MD, Prof.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MAC110

Identifier Type: -

Identifier Source: org_study_id